Division of Psychology & Mental Health, Faculty of Biology, Medicine & Health, University of Manchester, M13 9PL, UK.
NCISH, Centre for Mental Health and Safety, Faculty of Biology, Medicine and Health, University of Manchester, M13 9PL, UK.
Schizophr Res. 2024 May;267:254-260. doi: 10.1016/j.schres.2024.03.048. Epub 2024 Apr 5.
Suicide is the leading cause of unnatural death among people with schizophrenia. Substance use is a highly prevalent comorbid feature of schizophrenia and a modifiable risk factor for suicide. However, no studies have examined changes in the frequency of substance use or self-poisoning in those who died by suicide over time. Knowing this could support more tailored approaches to reducing specific risk factors and access to means in those with schizophrenia who are at risk of suicide. We conducted an 11-year observational study on a clinical survey of people with schizophrenia in the UK who died by suicide within 12 months of contact with mental health services between 2010 and 2020 (n = 2718). Overall, alcohol, cannabis and stimulants were the most frequently reported substances. The odds of lifetime use significantly increased over time for cannabis, stimulants, heroin, and benzodiazepines. There were differences in socio-demographic, behavioural and clinical factors between those with recent and historical alcohol and drug use before death. Deaths by hanging, jumping and self-poisoning were the most common suicide methods. Though deaths by hanging significantly increased over time, deaths by self-poisoning significantly decreased, especially by means of psychotropic medication and opioids. To improve risk management, clinical efforts should focus on identifying and treating people with schizophrenia using specific substances. Nationwide initiatives for improving safety in prescribing could be contributing to reduced risks of suicide via self-poisoning in this group.
自杀是精神分裂症患者非自然死亡的主要原因。物质使用是精神分裂症的一个高度普遍的共病特征,也是自杀的一个可改变的风险因素。然而,没有研究调查过随着时间的推移,自杀死亡者的物质使用或自我中毒的频率变化。了解这一点可以支持在有自杀风险的精神分裂症患者中,采取更有针对性的方法来减少特定的风险因素和获取手段。我们对 2010 年至 2020 年期间,在英国接触精神卫生服务后 12 个月内自杀的精神分裂症患者进行了一项为期 11 年的临床调查(n=2718)。总体而言,酒精、大麻和兴奋剂是最常报告的物质。终生使用的可能性随着时间的推移显著增加,包括大麻、兴奋剂、海洛因和苯二氮䓬类药物。在死亡前最近和历史上使用酒精和药物的人群中,存在社会人口统计学、行为和临床因素的差异。上吊、跳楼和自我中毒是最常见的自杀方法。尽管上吊自杀的比例随着时间的推移显著增加,但自我中毒的比例显著下降,尤其是通过精神药物和阿片类药物。为了改善风险管理,临床工作应重点识别和治疗使用特定物质的精神分裂症患者。全国范围内提高处方安全性的举措可能有助于降低该人群的自杀风险。